Article
No correlation between TIMP2 -418 G>C polymorphism and increased risk of cancer: evidence from a meta-analysis.
PloS one - 1 Jan 2014
Mandal Raju K, Akhter Naseem, Haque Shafiul, Panda Aditya K, Mittal Rama D, Alqumber Mohammed A A
Abstract excerpt
AIM: Tissue inhibitor of metalloproteinase (TIMP2) is involved in the regulation of matrix metalloproteinase 2 (MMP2) and shown to implicate in cancer development and progression. The results from the published studies based on the association between TIMP2 -418 G>C polymorphism and cancer risk are inconsistent. In this meta-analysis, we aimed to evaluate the potential association between TIMP2 -418 G>C...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
